EyePoint, Inc.
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.99 USD
−130.87 M USD
43.27 M USD
73.29 M
About EyePoint, Inc.
Sector
Industry
CEO
Jay S. Duker
Website
Headquarters
Watertown
Founded
1987
Identifiers
3
ISINUS30233G2093
EyePoint Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of EYPT is 18.38 USD — it has decreased by −2.49% in the past 24 hours. Watch EyePoint, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange EyePoint, Inc. stocks are traded under the ticker EYPT.
EYPT stock has risen by 12.69% compared to the previous week, the month change is a 34.85% rise, over the last year EyePoint, Inc. has showed a 158.15% increase.
We've gathered analysts' opinions on EyePoint, Inc. future price: according to them, EYPT price has a max estimate of 68.00 USD and a min estimate of 20.00 USD. Watch EYPT chart and read a more detailed EyePoint, Inc. stock forecast: see what analysts think of EyePoint, Inc. and suggest that you do with its stocks.
EYPT reached its all-time high on Jan 27, 2005 with the price of 485.60 USD, and its all-time low was 2.19 USD and was reached on Dec 16, 2022. View more price dynamics on EYPT chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
EYPT stock is 7.84% volatile and has beta coefficient of 2.01. Track EyePoint, Inc. stock price on the chart and check out the list of the most volatile stocks — is EyePoint, Inc. there?
Today EyePoint, Inc. has the market capitalization of 1.56 B, it has increased by 6.69% over the last week.
Yes, you can track EyePoint, Inc. financials in yearly and quarterly reports right on TradingView.
EyePoint, Inc. is going to release the next earnings report on Mar 5, 2026. Keep track of upcoming events with our Earnings Calendar.
EYPT earnings for the last quarter are −0.85 USD per share, whereas the estimation was −0.77 USD resulting in a −10.49% surprise. The estimated earnings for the next quarter are −0.74 USD per share. See more details about EyePoint, Inc. earnings.
EyePoint, Inc. revenue for the last quarter amounts to 966.00 K USD, despite the estimated figure of 3.49 M USD. In the next quarter, revenue is expected to reach 1.04 M USD.
EYPT net income for the last quarter is −59.73 M USD, while the quarter before that showed −59.43 M USD of net income which accounts for −0.51% change. Track more EyePoint, Inc. financial stats to get the full picture.
No, EYPT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 24, 2025, the company has 165 employees. See our rating of the largest employees — is EyePoint, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EyePoint, Inc. EBITDA is −216.25 M USD, and current EBITDA margin is −333.50%. See more stats in EyePoint, Inc. financial statements.
Like other stocks, EYPT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EyePoint, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EyePoint, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EyePoint, Inc. stock shows the buy signal. See more of EyePoint, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.